Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
Lan T, Jiang S, Zhang J, Weng Q, Yu Y, Li H, Tian S, Ding X, Hu S, Yang Y, Wang W, Wang L, Luo D, Xiao X, Piao S, Zhu Q, Rong X, Guo J.
Lan T, et al. Among authors: luo d.
Hepatology. 2022 Jul;76(1):155-171. doi: 10.1002/hep.32221. Epub 2021 Dec 19.
Hepatology. 2022.
PMID: 34717002
Free PMC article.